Neogen Corporation (NEOG)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$9.24
-2.22%
Mkt Cap $2.05B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 9, 2026 | $204.49M | $211.20M | +3.28% | $0.04 | $0.09 | +125.00% | — | — |
| Q1 2026 Jan 8, 2026 | $207.71M | $224.69M | +8.18% | $0.07 | $0.10 | +42.86% | — | — |
| Q4 2025 Oct 9, 2025 | $203.09M | $209.19M | +3.00% | -$0.07 | $0.04 | +154.05% | — | — |
| Q3 2025 Jul 29, 2025 | $202.67M | $225.46M | +11.25% | $0.08 | $0.05 | -37.50% | — | — |
| Q2 2025 Apr 9, 2025 | $222.53M | $220.98M | -0.70% | $0.13 | $0.10 | -23.08% | — | — |
| Q1 2025 Jan 10, 2025 | $228.07M | $231.26M | +1.40% | $0.09 | $0.11 | +22.22% | — | — |
| Q4 2024 Oct 10, 2024 | $215.05M | $216.96M | +0.89% | $0.09 | $0.07 | -17.65% | — | — |
| Q3 2024 Jul 30, 2024 | $225.83M | $236.79M | +4.85% | $0.12 | $0.10 | -16.67% | — | — |
| Q2 2024 Apr 9, 2024 | $235.75M | $228.81M | -2.94% | $0.14 | $0.12 | -14.29% | — | — |
| Q1 2024 Jan 9, 2024 | $232.87M | $229.63M | -1.39% | $0.15 | $0.11 | -26.67% | — | — |
| Q4 2023 Oct 10, 2023 | $231.10M | $228.99M | -0.91% | $0.14 | $0.11 | -21.43% | — | — |
| Q3 2023 Jul 27, 2023 | $227.65M | $241.81M | +6.22% | $0.10 | $0.14 | +40.00% | — | — |
| Q1 2023 Mar 30, 2023 | $218.86M | $218.25M | -0.28% | $0.03 | $0.12 | +366.74% | — | — |
| Q1 2023 Jan 5, 2023 | $228.30M | $230.03M | +0.76% | -$0.08 | $0.15 | +287.50% | — | — |
| Q3 2022 Sep 27, 2022 | $135.75M | $132.35M | -2.51% | $0.16 | $0.15 | -6.25% | — | — |
| Q3 2022 Jul 26, 2022 | $138.37M | $140.09M | +1.25% | $0.12 | $0.14 | +16.67% | — | — |
| Q1 2022 Mar 24, 2022 | $130.00M | $128.24M | -1.35% | $0.15 | $0.13 | -13.33% | — | — |
| Q4 2021 Dec 21, 2021 | $129.99M | $130.52M | +0.41% | $0.17 | $0.17 | +0.00% | — | — |
| Q3 2021 Sep 21, 2021 | $119.75M | $128.31M | +7.14% | $0.16 | $0.16 | +0.00% | — | — |
| Q3 2021 Jul 20, 2021 | $121.20M | $127.42M | +5.14% | $0.17 | $0.15 | -11.76% | — | — |